Immunostics 100-101 Hemochroma PLUS Analyzer CLIA

The Immunostics 100-101 Hemochroma PLUS Analyzer is a cutting-edge medical device designed for use in clinical settings, providing rapid and accurate results for hemochromatosis screening. This innovative analyzer offers a convenient and efficient solution for healthcare professionals, allowing for timely diagnosis and treatment. With its CLIA-waived status, this device is ideal for use in a variety of settings, from hospitals to outpatient clinics.

The Immunostics 100-101 Hemochroma PLUS Analyzer is a specialized device used for the quantitative measurement of transferrin saturation and calculation of total iron binding capacity. This analyzer provides healthcare professionals with a valuable tool for detecting and managing hemochromatosis, a genetic disorder characterized by excessive iron accumulation in the body. By offering a simple and accurate testing method, this device enables healthcare providers to make informed decisions regarding patient care and treatment.

Key Features

• CLIA-waived for use in moderate-complexity laboratories and waived testing sites
• Provides rapid results for hemochromatosis screening, enabling timely diagnosis and treatment
• Quantitative measurement of transferrin saturation and calculation of total iron binding capacity
• Easy-to-use interface and compact design, suitable for various clinical settings
• Reliable and accurate results, supporting informed decision-making for healthcare professionals
• Supports early detection and management of hemochromatosis, a genetic disorder affecting iron metabolism
• Streamlines laboratory workflow, reducing the need for manual calculations and minimizing errors

Product Specifications

Dimensions: 12 inches (width) x 10 inches (depth) x 8 inches (height) | Weight: 15 pounds | Materials: Durable plastic and metal construction | Compliance: CLIA-waived, FDA-cleared | Compatibility: Compatible with a range of sample types, including whole blood, serum, and plasma.

Ideal For

• Hospitals and inpatient facilities
• Outpatient clinics and physician offices
• Reference laboratories and moderate-complexity testing sites
• Public health organizations and research institutions
• Any setting requiring rapid and accurate hemochromatosis screening and diagnosis